Products for Research Use Only

Carazolol-d7

CAT: 0804-HY-107327S-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-107327S-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Carazolol-d7 is the deuterium labeled Carazolol. Carazolol is a highly potent antagonist of β1/β2 adrenoceptor. Carazolol is also a potent, selective β3-adrenoceptor agonist. Carazolol can be used in the research of hypertension[1].
CAS Number
1173021-02-7
Product Name Alternative
(±) -Carazolol-d7; DL-Carazolol-d7; Suacron-d7
UNSPSC
12352005
Hazard Statement
H302-H319
Target
Adrenergic Receptor; Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
GPCR/G Protein; Neuronal Signaling; Others
Field of Research
Cardiovascular Disease
Purity
99.0
Solubility
10 mM in DMSO|DMSO : 100mg/mL (ultrasonic)
Smiles
[2H]C([2H])([2H])C(C([2H])([2H])[2H])([2H])NCC(O)COC1=C2C3=CC=CC=C3NC2=CC=C1
Molecular Formula
C18H15D7N2O2
Molecular Weight
305.42
Precautions
P264-P270-P280-P305+P351+P338-P330-P501
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported